Hit Compounds Enter POC Evaluation Stage in DNDi’s NTD Drug Discovery Booster Project

Dr Charles Mowbray, head of drug discovery at DNDi A drug discovery booster project for neglected tropical diseases (NTDs), an initiative of the Drugs for Neglected Diseases initiative (DNDi) and five drug makers including three Japanese companies, is making steady...read more